US8592581, 3

ID: ALA3655764

Chembl Id: CHEMBL3655764

PubChem CID: 25020379

Max Phase: Preclinical

Molecular Formula: C20H27ClN6O

Molecular Weight: 402.93

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](Nc1nc(NCc2cccc(Cl)c2)c2ncn(C(C)C)c2n1)[C@@H](C)O

Standard InChI:  InChI=1S/C20H27ClN6O/c1-5-16(13(4)28)24-20-25-18(22-10-14-7-6-8-15(21)9-14)17-19(26-20)27(11-23-17)12(2)3/h6-9,11-13,16,28H,5,10H2,1-4H3,(H2,22,24,25,26)/t13-,16+/m1/s1

Standard InChI Key:  RMHPTNZDIDOFNC-CJNGLKHVSA-N

Associated Targets(Human)

CDK9 Tchem Cyclin-dependent kinase 9 (2495 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem Cyclin-dependent kinase 2 (9050 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 402.93Molecular Weight (Monoisotopic): 402.1935AlogP: 4.24#Rotatable Bonds: 8
Polar Surface Area: 87.89Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.20CX LogP: 3.91CX LogD: 3.91
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -1.01

References

1.  (2013)  Trisubstituted purine derivatives, 

Source

Source(1):